Hematologic Cancer Clinical Trials

11 recruiting

Hematologic Cancer Trials at a Glance

13 actively recruiting trials for hematologic cancer are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Boston, Houston, and Allentown. Lead sponsors running hematologic cancer studies include Avera McKennan Hospital & University Health Center, Baylor College of Medicine, and AbbVie.

Browse hematologic cancer trials by phase

Treatments under study

About Hematologic Cancer Clinical Trials

Looking for clinical trials for Hematologic Cancer? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematologic Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematologic Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Breast CancerOvarian CancerEndometrial Cancer+9 more
Avera McKennan Hospital & University Health Center25,000 enrolled6 locationsNCT05142033
Recruiting
Not Applicable

Early Detection of Complications During Immunotherapy for Haematological Malignancy

Hematologic CancerCRS - Cytokine Release Syndrome
Rigshospitalet, Denmark100 enrolled1 locationNCT06377059
Recruiting
Not Applicable

Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy

Hematologic Cancer
Instituto de Investigacion Sanitaria INCLIVA100 enrolled2 locationsNCT07173166
Recruiting
Not Applicable

Discontinuation Study

CancerMultiple MyelomaHematologic Cancer
University College Cork70 enrolled1 locationNCT05866757
Recruiting

Genomic Profiling in Cancer Patients

Solid TumorsHematologic Cancers
Memorial Sloan Kettering Cancer Center200 enrolled18 locationsNCT01775072
Recruiting
Phase 1

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Hematologic Cancer
AbbVie340 enrolled51 locationsNCT05753501
Recruiting
Not Applicable

SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)

Thoracic CancerGastrointestinal CancerHematologic Cancer
Nadine McCleary, MD, MPH210 enrolled3 locationsNCT05375643
Recruiting
Not Applicable

Improving Comprehensive Care of Cancer Patients

Breast CancerGastrointestinal CancerHematologic Cancer
Baylor College of Medicine340 enrolled1 locationNCT05323409
Recruiting
Not Applicable

Hypnosis: a Path to Appeasement

Hematologic Cancer
Hospices Civils de Lyon50 enrolled1 locationNCT05942885
Recruiting
Not Applicable

An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors

Solid Tumor, AdultHematologic CancerSolid Tumor, Childhood
Gustave Roussy, Cancer Campus, Grand Paris160 enrolled1 locationNCT05481502
Recruiting
Not Applicable

Intervention for Fatigue in HCT Recipients

Hematologic MalignancyHematologic Cancer
Massachusetts General Hospital66 enrolled1 locationNCT05715047
Recruiting

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Non-hematologic Cancer
Sequenom, Inc.3,000 enrolled1 locationNCT02586389
Recruiting
Not Applicable

Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation

Hematologic Cancer
Universidad del Desarrollo30 enrolled1 locationNCT06260111